Tirzepatide has emerged as a groundbreaking medication for type 2 diabetes, offering promising results. However, the expense of this innovative drug and its access have become key issues for patients and healthcare practitioners. While tirzepatide has been cleared by regulatory agencies, its high-priced nature presents a significant obstacle to ma